Karen Reckamp

Karen Reckamp

UNVERIFIED PROFILE

Are you Karen Reckamp?   Register this Author

Register author
Karen Reckamp

Karen Reckamp

Publications by authors named "Karen Reckamp"

Are you Karen Reckamp?   Register this Author

100Publications

2816Reads

7Profile Views

Monitoring therapeutic response and resistance: analysis of circulating tumor DNA in patients with ALK+ lung cancer.

J Thorac Oncol 2019 Aug 22. Epub 2019 Aug 22.

Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, 1211 Medical Center Drive, Nashville, TN 37232; Vanderbilt-Ingram Cancer Center, 2220 Pierce Avenue, Nashville, TN 37232.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.08.003DOI Listing
August 2019

Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion.

J Thorac Oncol 2019 Feb;14(2):e29-e30

City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.10.169DOI Listing
February 2019

Real-World Pseudoprogression: an Uncommon Phenomenon.

Authors:
Karen L Reckamp

J Thorac Oncol 2018 07;13(7):880-882

City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.011DOI Listing
July 2018

Targeted Therapy for Patients With Metastatic Non-Small Cell Lung Cancer.

Authors:
Karen L Reckamp

J Natl Compr Canc Netw 2018 05;16(5S):601-604

Presented by Karen L. Reckamp, MD, MS, City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2018.0046DOI Listing
May 2018

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).

J Clin Oncol 2017 Dec 12;35(35):3924-3933. Epub 2017 Oct 12.

Leora Horn, Vanderbilt-Ingram Cancer Center; David R. Spigel, Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN; Everett E. Vokes, University of Chicago, Chicago, IL; Esther Holgado, Hospital De Madrid, Norte Sanchinarro, Madrid; Enriqueta Felip, Hospital Universitari Vall d'Hebron, Barcelona; Luis Paz-Ares, Hospital Universitario Virgen Del Rocio, Seville, Spain; Neal Ready, Duke University Medical Center, Durham, NC; Martin Steins, Thoraxklinik-Heidelberg gGmbH, Heidelberg; Martin Kohlhäeufl, Robert-Bosch-Krankenhaus, Stuttgart; Martin Reck, LungenClinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Wilfried E.E. Eberhardt, University Hospital and Ruhrlandclinic, University of Duisburg-Essen, Essen, Germany; Elena Poddubskaya, N.N. Blokhin Russian Cancer Research Center, Moscow, Russia; Hossein Borghaei, Fox Chase Cancer Center, Philadelphia, PA; Adam Pluzanski, Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warsaw, Poland; Karen L. Reckamp, City of Hope, Duarte, CA; Marco A. Burgio and Lucio Crinò, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Scientifico Romagnolo Per lo Studio e la Cura dei Tumori, Meldola, Italy; David Waterhouse, Oncology Hematology Care (OHC)/US Oncology, Cincinnati, OH; Fabrice Barlesi, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Marseille; Jérôme Fayette, Léon Bérard, Lyon, France; Scott Antonia, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Oscar Arrieta, Instituto Nacional De Cancerologia, Mexico City, Mexico; Naiyer Rizvi and Matthew D. Hellmann, Memorial Sloan Kettering Cancer Center, New York, NY; William J. Geese, Ang Li, Anne Blackwood-Chirchir, and Diane Healey, Bristol-Myers Squibb, Princeton, NJ; and Julie Brahmer, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.3062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075826PMC
December 2017

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

J Clin Oncol 2017 Aug 5;35(22):2490-2498. Epub 2017 May 5.

Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5904DOI Listing
August 2017

Triptolide-Assisted Phosphorylation of p53 Suppresses Inflammation-Induced NF-κB Survival Pathways in Cancer Cells.

Mol Cell Biol 2017 08 14;37(15). Epub 2017 Jul 14.

Department of Cancer Genetics and Epigenetics, City of Hope National Medical Center and Beckman Research Institute, Duarte, California, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/MCB.00149-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514447PMC
August 2017

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).

J Clin Oncol 2017 Jul 10;35(19):2184-2192. Epub 2017 May 10.

Martin J. Edelman, University of Maryland Greenebaum Cancer Center, Baltimore, MD; Xiaofei Wang and Lydia Hodgson, Alliance Statistical and Data Center, Duke University; Thomas E. Stinchcombe, Duke University School of Medicine, Durham, NC; Richard T. Cheney, Roswell Park Cancer Institute, Buffalo; Ajeet Gajra, State University of New York Upstate Medical University, Syracuse, NY; Maria Q. Baggstrom, Washington University School of Medicine, St Louis, MO; Sachdev P. Thomas, Illinois Cancer Care, Peoria; Paula N. Friedman and Everett E. Vokes, University of Chicago; Olwen M. Hahn, Alliance Protocol Office, University of Chicago, Chicago, IL; Erin Bertino, The Ohio State University Medical Center, Columbus, OH; Karen L. Reckamp, City of Hope Comprehensive Cancer Center, Duarte, CA; Julian Molina, Mayo Clinic, Rochester; Jon Ritter, University of Minnesota, Minneapolis, MN; Joan H. Schiller, University of Texas Southwestern Medical Center, Dallas, TX; Kisha Mitchell-Richards, Yale University, New Haven, CT; and Ginger Milne, Vanderbilt University, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.3743DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493050PMC
July 2017

Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?

Crit Care 2017 Jan 27;21(1):18. Epub 2017 Jan 27.

INSERM, Centre d'Étude des Pathologies Respiratoires, U1100, F-37032, Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13054-017-1602-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270208PMC
January 2017

NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.

J Natl Compr Canc Netw 2016 07;14(7):825-36

From The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; City of Hope Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Mayo Clinic Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0087DOI Listing
July 2016

Long-Term Effect of an Interdisciplinary Supportive Care Intervention for Lung Cancer Survivors After Surgical Procedures.

Ann Thorac Surg 2016 Feb 9;101(2):495-502; discussion 502-3. Epub 2015 Oct 9.

Division of Nursing Research and Education, Department of Population Sciences, City of Hope Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2015.07.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718894PMC
February 2016

Interdisciplinary Palliative Care for Patients With Lung Cancer.

J Pain Symptom Manage 2015 Dec 19;50(6):758-67. Epub 2015 Aug 19.

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2015.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666729PMC
December 2015

Advances in immunotherapy for non-small cell lung cancer.

Authors:
Karen L Reckamp

Clin Adv Hematol Oncol 2015 Dec;13(12):847-53

City of Hope Comprehensive Cancer Center, Duarte, California.

View Article

Download full-text PDF

Source
December 2015

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.

N Engl J Med 2015 Jul 31;373(2):123-35. Epub 2015 May 31.

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (J.B.); the City of Hope Comprehensive Cancer Center, Duarte, CA (K.L.R.); the Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam (P.B.), Erasmus MC Cancer Institute, Rotterdam (J.G.A.), and Ziekenhuis Amphia, Breda (J.G.A.) - all in the Netherlands; the University Hospital of Perugia, Perugia (L.C.), and the Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (M.C.G.) - both in Italy; the Department of Medical Oncology, West German Cancer Center, Universitätsklinikum Essen, and the Ruhrlandklinik, Universität Duisburg-Essen, Essen (W.E.E.E.), the Thoraxklinik, Heidelberg University Hospital, Heidelberg (M.S.), and the LungenClinic Grosshansdorf, Grosshansdorf (M.R.) - all in Germany; the N.N. Blokhin Russian Cancer Research Center, Moscow (E.P.); the H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.A.); the Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland (A.P.); the University of Chicago Medicine and Biological Sciences, Chicago (E.E.V.); the Hospital Madrid Norte Sanchinarro (E.H.), the Hospital Universitario Fundación Jiménez Díaz, Madrid (M.D.), and the Hospital Universitario Virgen Del Rocío, Seville (L.P.-A.) - all in Spain; Oncology Hematology Care, Cincinnati (D.W.); the Duke University Medical Center, Durham, NC (N.R.); Massachusetts General Hospital, Boston (J.G.); Centro Internacional de Estudios Clinicos, Santiago, Chile (O.A.F.); Nemocnice Na Bulovce, Prague, Czech Republic (L.H.); Bristol-Myers Squibb, Princeton, NJ (C.B., C.T.H., B.L.); and the Sarah Cannon Research Institute and Tennessee Oncology, Nashville (D.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1504627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400PMC
July 2015

Non-Small Cell Lung Cancer, Version 6.2015.

J Natl Compr Canc Netw 2015 May;13(5):515-24

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; University of Washington/Seattle Cancer Care Alliance; Huntsman Cancer Institute at the University of Utah; UC San Diego Moores Cancer Center; Fox Chase Cancer Center; University of Colorado Cancer Center; Roswell Park Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; Duke Cancer Institute; Moffitt Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; City of Hope Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; The University of Texas MD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Michigan Comprehensive Cancer Center; Stanford Cancer Institute; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0071DOI Listing
May 2015

Future of ALK inhibition in non-small-cell lung cancer.

Authors:
Karen L Reckamp

Lancet Oncol 2014 Sep 18;15(10):1047-9. Epub 2014 Aug 18.

City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(14)70390-0DOI Listing
September 2014

PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.

Mol Cancer Res 2014 May 27;12(5):765-74. Epub 2014 Jan 27.

Authors' Affiliations: Departments of Medicine, 2Pathology and Laboratory Medicine, 3Molecular and Medical Pharmacology, 4Anesthesiology, and 5Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles; 6UCLA Jonsson Comprehensive Cancer Center; 7West Los Angeles VA Healthcare System, Los Angeles; 8City of Hope Comprehensive Cancer Center, Duarte, California; and 9Boston University, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-13-0377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020971PMC
May 2014

EGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung.

J Natl Compr Canc Netw 2013 Sep;11(9):1040-4

From aCity of Hope Comprehensive Cancer Center, Duarte, California; bDavid Geffen School of Medicine at UCLA, Los Angeles, California; and cCedars Sinai Medical Center, Hollywood, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0126DOI Listing
September 2013

Sexuality, lung cancer, and the older adult: an unlikely trio?

J Adv Pract Oncol 2013 Sep;4(5):331-40

City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093438PMC
September 2013

CCL21 Chemokine Therapy for Lung Cancer.

Int Trends Immun 2013 Jan;1(1):10-15

Department of Medicine, UCLA Lung Cancer Research Program, David Geffen School of Medicine at UCLA ; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA ; Molecular Gene Medicine Laboratory, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175527PMC
January 2013

Phosphatidylinositol-3-kinase pathway.

Authors:
Karen L Reckamp

J Thorac Oncol 2012 Dec;7(16 Suppl 5):S383-4

Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826df11cDOI Listing
December 2012

Antiangiogenic agents as second-line therapy for advanced non-small cell lung cancer.

Authors:
Karen L Reckamp

Cancer Lett 2012 Aug 3;321(2):101-9. Epub 2012 Feb 3.

Department of Medical Oncology and Therapeutics Research, City of Hope and Beckman Research Institute, 1500 E. Duarte Rd., MOB 1001, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2012.01.041DOI Listing
August 2012

Is benefit of maintenance therapy for NSCLC best defined by progression-free survival?

Authors:
Karen L Reckamp

Lancet Oncol 2012 May 17;13(5):435-6. Epub 2012 Apr 17.

City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70157-2DOI Listing
May 2012

Predictors of finding benefit after lung cancer diagnosis.

Psychooncology 2012 Apr 20;21(4):365-73. Epub 2011 Jan 20.

Division of Psychology, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1904DOI Listing
April 2012

Antiangiogenic and antimetastatic activity of JAK inhibitor AZD1480.

Cancer Res 2011 Nov 15;71(21):6601-10. Epub 2011 Sep 15.

Department of Cancer Immunotherapeutics, Medical Oncology, Molecular Medicine, and Graduate School of Biological Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/content/71/21/6601.full.pd
Web Search
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-11-1217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206173PMC
November 2011

Novel mechanisms and targets: miscellaneous agents.

Authors:
Karen L Reckamp

J Thorac Oncol 2011 Nov;6(11 Suppl 4):S1812-4

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153264
Publisher Site
http://dx.doi.org/10.1097/01.JTO.0000407569.29900.73DOI Listing
November 2011

Combination chemotherapy for older adults with advanced non-small-cell lung cancer.

Authors:
Karen L Reckamp

Lancet 2011 Sep 8;378(9796):1055-7. Epub 2011 Aug 8.

City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(11)61259-2DOI Listing
September 2011

STAT3: a target to enhance antitumor immune response.

Curr Top Microbiol Immunol 2011 ;344:41-59

Beckman Research Institute, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/82_2010_51DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244828PMC
June 2011

Management of non-small-cell lung cancer in the older adult.

Maturitas 2011 Apr 3;68(4):311-21. Epub 2011 Feb 3.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2011.01.008DOI Listing
April 2011

City of Hope Cancer Center hematology-oncology fellowship and hematopoietic stem cell transplantation fellowship.

Am J Hematol 2011 Feb;86(2):197-8

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.21919
Publisher Site
http://dx.doi.org/10.1002/ajh.21919DOI Listing
February 2011

Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling.

J Thorac Oncol 2010 Dec;5(12 Suppl 6):S487-9

Department of Medical Oncology & Therapeutics Research, City of Hope and Beckman Research Institute, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.JTO.0000391378.17179.8fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192015PMC
December 2010

Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.

Cancer Res 2010 Dec 30;70(23):9599-610. Epub 2010 Nov 30.

Department of Cancer Immunotherapeutics & Tumor Immunology, Beckman Research Institute at City of Hope, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-10-1293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017475PMC
December 2010

Akt inhibitors in clinical development for the treatment of cancer.

Expert Opin Investig Drugs 2010 Nov 16;19(11):1355-66. Epub 2010 Sep 16.

City of Hope Comprehensive Cancer Center, Department of Medical Oncology & Experimental Therapeutics, 1500 East Duarte Road, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2010.520701DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244346PMC
November 2010

Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.

Cancer Res 2010 Oct 14;70(19):7455-64. Epub 2010 Sep 14.

Department of Cancer Immunotherapeutics and Tumor Immunology, Beckman Research Institute, City of Hope National Medical Center, Duarte, California 91010-3000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-0736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058618PMC
October 2010

Targeted therapies for non-small cell lung cancer: an evolving landscape.

Mol Cancer Ther 2010 Jul 22;9(7):1931-44. Epub 2010 Jun 22.

Division of Genitourinary Malignancies, Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-10-0239DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244351PMC
July 2010

Molecular origins of lung cancer: prospects for personalized prevention and therapy.

J Thorac Oncol 2010 Jun;5(6 Suppl 3):S207-13

Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181e2f682DOI Listing
June 2010

Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.

Mol Cell Proteomics 2009 Dec 23;8(12):2746-58. Epub 2009 Sep 23.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5G1X5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M900134-MCP200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816016PMC
December 2009

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

BMC Cancer 2009 Jun 29;9:213. Epub 2009 Jun 29.

Department of Medical Oncology & Therapeutics Research, City of Hope and Beckman Research Institute, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-9-213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708193PMC
June 2009

Non-small cell lung cancer in the elderly: defining treatment options.

Semin Oncol 2008 Dec;35(6):590-6

Department of Medical Oncology and Therapeutics Research, City of Hope and Beckman Research Institute, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2008.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701401PMC
December 2008

The role of targeting mammalian target of rapamycin in lung cancer.

Clin Lung Cancer 2008 Nov;9(6):340-5

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304117023
Publisher Site
http://dx.doi.org/10.3816/CLC.2008.n.049DOI Listing
November 2008

An interdisciplinary care approach for integration of palliative care in lung cancer.

Clin Lung Cancer 2008 Nov;9(6):352-60

Department of Nursing Research & Education, Division of Population Sciences, City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2008.n.051DOI Listing
November 2008

Chemokines as therapeutic targets in renal cell carcinoma.

Expert Rev Anticancer Ther 2008 Jun;8(6):887-93

Divisions of Medical Oncology and Therapeutics Research & Hematology, City of Hope and Beckman Research Institute, 1500 E Duarte Road, MOB 1001, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.8.6.887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2884168PMC
June 2008

A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.

Clin Cancer Res 2008 Mar;14(5):1355-62

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-4117DOI Listing
March 2008

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

Expert Rev Anticancer Ther 2007 Oct;7(10):1405-21

David Geffen School of Medicine at UCLA, Division of Pulmonary & Critical Care Medicine & Hospitalists, Department of Medicine, UCLA Lung Cancer Research Program, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.10.1405DOI Listing
October 2007

Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.

Mol Cancer 2006 Nov 3;5:56. Epub 2006 Nov 3.

Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-5-56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1636662PMC
November 2006

A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.

Clin Cancer Res 2006 Jun;12(11 Pt 1):3381-8

Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine at University of California at Los Angeles, 90095, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0112DOI Listing
June 2006

The potential and rationale for COX-2 inhibitors in lung cancer.

Anticancer Agents Med Chem 2006 May;6(3):209-20

David Geffen School of Medicine at UCLA, Lung Cancer Research Program, 37-131 CHS, 10833 Le Conte Avenue, Los Angeles, California 90095-1690, USA.

View Article

Download full-text PDF

Source
May 2006